These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 15859325)
1. [Screening of TACE peptide inhibitors from a phage display random 15-peptide library by recombinant TACE ecotodomain]. Huang W; Li LB; Han L; Zhang H; Yang YZ Sheng Wu Gong Cheng Xue Bao; 2005 Jan; 21(1):30-5. PubMed ID: 15859325 [TBL] [Abstract][Full Text] [Related]
2. Screening of TACE peptide inhibitors from phage display peptide library. Huang W; Li L; Han L; Yang Y J Huazhong Univ Sci Technolog Med Sci; 2005; 25(5):473-6. PubMed ID: 16463648 [TBL] [Abstract][Full Text] [Related]
3. [Inhibition of proliferation, adhesion and invasion ability of human lung carcinoma cell A549 by tumor necrosis factor-alpha converting enzyme (TACE)]. Yan Y; Li XO; Zhang J; Huang W; Li LB; Yang YZ Sheng Wu Gong Cheng Xue Bao; 2007 Jul; 23(4):584-8. PubMed ID: 17822026 [TBL] [Abstract][Full Text] [Related]
4. The study of the inhibition of the recombinant TACE prodomain to endotoxemia in mice. Li X; Yan Y; Huang W; Yang Y Int J Mol Sci; 2009 Dec; 10(12):5442-5454. PubMed ID: 20054479 [TBL] [Abstract][Full Text] [Related]
5. The regulation of TACE catalytic function by its prodomain. Li X; Yan Y; Huang W; Yang Y; Wang H; Chang L Mol Biol Rep; 2009 Apr; 36(4):641-51. PubMed ID: 18386160 [TBL] [Abstract][Full Text] [Related]
6. Ectodomain shedding of TNF-alpha is enhanced by nardilysin via activation of ADAM proteases. Hiraoka Y; Yoshida K; Ohno M; Matsuoka T; Kita T; Nishi E Biochem Biophys Res Commun; 2008 May; 370(1):154-8. PubMed ID: 18355445 [TBL] [Abstract][Full Text] [Related]
7. Characterization of the cDNA and gene for mouse tumour necrosis factor alpha converting enzyme (TACE/ADAM17) and its location to mouse chromosome 12 and human chromosome 2p25. Cerretti DP; Poindexter K; Castner BJ; Means G; Copeland NG; Gilbert DJ; Jenkins NA; Black RA; Nelson N Cytokine; 1999 Aug; 11(8):541-51. PubMed ID: 10433800 [TBL] [Abstract][Full Text] [Related]
9. Increased expression of tumor necrosis factor-alpha converting enzyme and tumor necrosis factor-alpha in peripheral blood mononuclear cells in patients with advanced congestive heart failure. Satoh M; Iwasaka J; Nakamura M; Akatsu T; Shimoda Y; Hiramori K Eur J Heart Fail; 2004 Dec; 6(7):869-75. PubMed ID: 15556048 [TBL] [Abstract][Full Text] [Related]
10. Cutting edge: a dominant negative form of TNF-alpha converting enzyme inhibits proTNF and TNFRII secretion. Solomon KA; Pesti N; Wu G; Newton RC J Immunol; 1999 Oct; 163(8):4105-8. PubMed ID: 10510344 [TBL] [Abstract][Full Text] [Related]
11. Blockade of tumor necrosis factor-α converting enzyme (TACE) enhances IL-1β and IFN-γ via caspase-1 activation: a probable cause for loss of efficacy of TACE inhibitors in humans? Sharma M; Mohapatra J; Acharya A; Deshpande SS; Chatterjee A; Jain MR Eur J Pharmacol; 2013 Feb; 701(1-3):106-13. PubMed ID: 23266381 [TBL] [Abstract][Full Text] [Related]
12. Phage display of functional human TNF-alpha converting enzyme catalytic domain: a rapid method for the production of stabilized proteolytic proteins for assay development and high-throughput screening. Chen Y; Diener K; Patel IR; Kawooya JK; Martin GA; Yamdagni P; Zhang X; Sandrasalphaa A; Sahasrabudhe S; Busch SJ J Biomol Screen; 2002 Oct; 7(5):433-40. PubMed ID: 14599359 [TBL] [Abstract][Full Text] [Related]
13. Definition of peptide inhibitors from a synthetic peptide library by targeting gelatinase B/matrix metalloproteinase-9 (MMP-9) and TNF-α converting enzyme (TACE/ADAM-17). Qiu Z; Yan M; Li Q; Liu D; Van den Steen PE; Wang M; Opdenakker G; Hu J J Enzyme Inhib Med Chem; 2012 Aug; 27(4):533-40. PubMed ID: 21827363 [TBL] [Abstract][Full Text] [Related]
15. Structure-based rational design of peptide hydroxamic acid inhibitors to target tumor necrosis factor-α converting enzyme as potential therapeutics for hepatitis. Wu D; Gu Q; Zhao N; Xia F; Li Z J Drug Target; 2015 Dec; 23(10):936-42. PubMed ID: 26061299 [TBL] [Abstract][Full Text] [Related]
16. Unlike for human monocytes after LPS activation, release of TNF-α by THP-1 cells is produced by a TACE catalytically different from constitutive TACE. Moreira-Tabaka H; Peluso J; Vonesch JL; Hentsch D; Kessler P; Reimund JM; Dumont S; Muller CD PLoS One; 2012; 7(3):e34184. PubMed ID: 22479555 [TBL] [Abstract][Full Text] [Related]
17. The P2/P2' sites affect the substrate cleavage of TNF-α converting enzyme (TACE). Liu S; Liu S; Wang Y; Liao Z Mol Immunol; 2014 Nov; 62(1):122-8. PubMed ID: 24980871 [TBL] [Abstract][Full Text] [Related]
18. [Preparation and identification of a single chain antibody against the shedding site of N-cadherin cleaved by ADAM10]. Li X; Huang W; Li L; Zhou L Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Sep; 29(9):949-52. PubMed ID: 24011157 [TBL] [Abstract][Full Text] [Related]
19. TNF-alpha convertase enzyme from human arthritis-affected cartilage: isolation of cDNA by differential display, expression of the active enzyme, and regulation of TNF-alpha. Patel IR; Attur MG; Patel RN; Stuchin SA; Abagyan RA; Abramson SB; Amin AR J Immunol; 1998 May; 160(9):4570-9. PubMed ID: 9574564 [TBL] [Abstract][Full Text] [Related]
20. Expression and purification of correctly processed, active human TACE catalytic domain in Saccharomyces cerevisiae. Clarke HR; Wolfson MF; Rauch CT; Castner BJ; Huang CP; Gerhart MJ; Johnson RS; Cerretti DP; Paxton RJ; Price VL; Black RA Protein Expr Purif; 1998 Jun; 13(1):104-10. PubMed ID: 9631522 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]